Education
About Us
Working with TipRanks
Follow Us
Moleculin Biotech (DE:MOL)
FRANKFURT:MOL
Moleculin Biotech (MOL) Ownership Overview
3.49% Insiders
0.22%
Mutual Funds
0.36% Other Institutional Investors
0.29% ETFs
95.65% Public Companies and
Individual Investors
The ownership structure of Moleculin Biotech (DE:MOL) stock is a mix of institutional, retail, and individual investors. Approximately 0.86% of the company’s stock is owned by Institutional Investors, 3.49% is owned by Insiders, and 95.65% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 23, 2025 | xxxxxxxxxxxxx | $250000 | |
Jun 23, 2025 | xxxxxxxxxxxxx | $100000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 743,607 | Insider | 2.46% | 5,579,283 | |
| 287,587 | Insider | 0.95% | 2,157,765 | |
| 87,486 | Institution | 0.29% | 656,407 | |
| 34,871 | Institution | 0.12% | 261,637 | |
| 30,314 | Institution | 0.10% | 227,446 | |
| 14,660 | Insider | 0.05% | 109,994 | |
| 10,152 | Insider | 0.03% | 76,170 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 34,871 | Institution | 0.12% | 261,637 | |
| 30,314 | Institution | 0.10% | 227,446 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Moleculin Biotech (DE:MOL)?
According to the latest TipRanks data, approximately 0.36% of the company's stock is held by institutional investors, 3.49% is held by insiders, and 95.65% is held by retail investors.
What percentage of Moleculin Biotech (DE:MOL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.36% of Moleculin Biotech (DE:MOL) stock is held by institutional investors.
What percentage of Moleculin Biotech (DE:MOL) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.65% of Moleculin Biotech (DE:MOL) stock is held by retail investors.
Who owns the most shares of Moleculin Biotech (DE:MOL)?
WALTER V KLEMP owns the most shares of Moleculin Biotech (DE:MOL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.